 Colfax Corps NYSE: CFX price target has been lowered to 52 an upside of 41 from 60 by KeyBanc analyst Jeffrey Hammond, following ESABEnoviss 2022 Investor Day to reflect broadly lower peer multiples. The analyst maintained an Overweight rating on CFX. 